Literature DB >> 3537245

Short- and long-term effects of furosemide on lung function in infants with bronchopulmonary dysplasia.

B Engelhardt, S Elliott, T A Hazinski.   

Abstract

Although furosemide improves lung mechanics in some infants with broncho-pulmonary dysplasia (BPD), this may not be important unless gas exchange also improves. To determine the relationship between improvement in mechanics and improvement in gas exchange, the short- and long-term effects of furosemide therapy were studied in 16 spontaneously breathing infants with severe BPD who were both oxygen dependent and hypercarbic (mean PCO2 54 +/- 11 torr). Each infant was examined at least three times: before furosemide therapy, 1 hour after the first dose of furosemide, and after a 6- to 10-day course. Ten of the 16 infants were also examined three times during a 7-day control period. Transcutaneous PO2 and PCO2, esophageal pressure, air flow, and tidal volume were measured. Pulmonary resistance, lung compliance, and the alveolar to skin PO2 difference were calculated. After a single dose of furosemide, only compliance significantly improved. After prolonged therapy, compliance, resistance, and oxygenation significantly improved in the group as a whole, but better oxygenation was achieved in only six of 16 infants. tcPCO2 was unaffected by long-term furosemide therapy, but in all infants with decreased tcPCO2 1 hour after a single dose, there was sustained decrease in PCO2 after prolonged therapy. Changes in gas exchange were not explained by changes in lung mechanics. These data indicate that long-term diuretic therapy can improve the mechanical properties of the lungs of spontaneously breathing infants with BPD, but that gas exchange is usually unaffected.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3537245     DOI: 10.1016/s0022-3476(86)80295-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  11 in total

Review 1.  A risk-benefit assessment of drugs used for neonatal chronic lung disease.

Authors:  D G Sweet; H L Halliday
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

Review 2.  Bronchopulmonary dysplasia: early diagnosis, prophylaxis, and treatment.

Authors:  A Greenough
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

Review 3.  Unexpected extra-renal effects of loop diuretics in the preterm neonate.

Authors:  Robert Cotton; Sandra Suarez; Jeff Reese
Journal:  Acta Paediatr       Date:  2012-05-28       Impact factor: 2.299

Review 4.  Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.

Authors:  Audra Stewart; Luc P Brion
Journal:  Cochrane Database Syst Rev       Date:  2011-09-07

5.  Acute Responses to Diuretic Therapy in Extremely Low Gestational Age Newborns: Results from the Prematurity and Respiratory Outcomes Program Cohort Study.

Authors:  Carol J Blaisdell; James Troendle; Anne Zajicek
Journal:  J Pediatr       Date:  2018-03-26       Impact factor: 4.406

Review 6.  Hypertension in infancy: diagnosis, management and outcome.

Authors:  Janis M Dionne; Carolyn L Abitbol; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2011-01-22       Impact factor: 3.714

7.  Urinary aldosterone excretion and electrolytic balance in response to chronic diuretic therapy in very low-birth weight infants.

Authors:  S Costa; F Cota; C Romagnoli; C Latella; L Maggio; F Gallini
Journal:  J Endocrinol Invest       Date:  2010-11-08       Impact factor: 4.256

8.  Mineral excretion following furosemide compared with bumetanide therapy in premature infants.

Authors:  S Shankaran; K C Liang; N Ilagan; L Fleischmann
Journal:  Pediatr Nephrol       Date:  1995-04       Impact factor: 3.714

Review 9.  Updates on Functional Characterization of Bronchopulmonary Dysplasia - The Contribution of Lung Function Testing.

Authors:  Anne Greenough; Anoop Pahuja
Journal:  Front Med (Lausanne)       Date:  2015-05-29

10.  Loop Diuretics in Severe Bronchopulmonary Dysplasia: Cumulative Use and Associations with Mortality and Age at Discharge.

Authors:  Nicolas A Bamat; Timothy D Nelin; Eric C Eichenwald; Haresh Kirpalani; Matthew M Laughon; Wesley M Jackson; Erik A Jensen; Kathleen A Gibbs; Scott A Lorch
Journal:  J Pediatr       Date:  2020-11-03       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.